- Report
- April 2026
- 160 Pages
Global
From €2977EUR$3,320USD£2,553GBP
€3722EUR$4,150USD£3,191GBP
- Report
- October 2025
- 160 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- October 2025
- 160 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- October 2025
- 160 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- October 2025
- 160 Pages
Global
From €2834EUR$3,160USD£2,430GBP
€3542EUR$3,950USD£3,037GBP
- Report
- September 2025
- 150 Pages
Global
From €3991EUR$4,450USD£3,422GBP
- Report
- October 2025
- 98 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- September 2025
- 101 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- September 2025
- 72 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- February 2026
- 95 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- February 2026
- 99 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- January 2026
- 100 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- December 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,729GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more